-
Isolation of Limb Circulation and Perfusion
-
Summary of Outcome Following Limb Salvage for Dogs with Osteosarcoma
-
Surgery for Nonappendicular and Less Common Appendicular Sites of OS
-
Radiation
-
Radioisotopes
-
Systemic Adjuvant Therapy for Dogs with Osteosarcoma
-
Chemotherapy
-
Cisplatin: Single Agent
-
Carboplatin: Single Agent
-
Lobaplatin: Single Agent
-
Doxorubicin: Single Agent
-
Doxorubicin/Cisplatin: Concurrent Combination
-
Doxorubicin/Carboplatin: Concurrent Combination
-
Doxorubicin/Cisplatin: Alternating Combination
-
Doxorubicin/Carboplatin: Alternating Combination
-
Carboplatin/Gemcitabine: Concurrent Combination
-
Preliminary Agents
-
Immunotherapy
-
Molecular-Targeted Therapies for Dogs with Osteosarcoma
-
Micrometastatic Adjuvant Setting
-
Treating Gross Metastatic Disease
-
Surgery
-
Chemotherapy and Receptor Tyrosine Kinase Inhibitors for Gross (Macroscopic) Osteosarcoma
-
Investigational Therapies for Gross Metastatic Disease
-
Aerosol Drug Delivery
-
Augmentation of Antitumor Immunity
-
Palliative Treatment: Primary and Metastatic Bone Cancer Pain
-
Bone Cancer Pain Physiology
-
Palliative Radiation Therapy
-
Radiopharmaceuticals
-
Aminobisphosphonates
-
Comparative Aspects
-
Bone Surface Osteosarcoma
-
Other Primary Bone Tumors of Dogs
-
Chondrosarcoma
-
Hemangiosarcoma
-
Fibrosarcoma
-
Multilobular Osteochondrosarcoma
-
Metastatic Tumors of Bone
-
Benign Tumors of Bone
-
Osteomas
-
Multiple Cartilaginous Exostosis
-
Bone Cysts
-
Primary Bone Tumors of Cats
-
Incidence and Risk Factors
-
Pathology and Natural Behavior
-
History and Clinical Signs
-
Diagnostic Work-Up
-
Therapy and Prognosis
-
Fibrosarcoma, Chondrosarcoma, and Hemangiosarcoma
-
References